To include your compound in the COVID-19 Resource Center, submit it here.

CHMP recommends HCV combos, spurns Ninlaro

EMA's CHMP recommended approval of HCV therapies from Gilead Sciences Inc. (NASDAQ:GILD) and Merck & Co Inc. (NYSE:MRK), but recommended against

Read the full 215 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE